TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

No More Tears for Johnson & Johnson?
Play
INVESTING

Johnson & Johnson Halts Development of Flu Treatment Candidate

  • By Tony Owusu
  • Sep 2, 2020 11:48 AM EDT
PRESS RELEASES

ALERT: Halper Sadeh LLP Is Investigating The Following Mergers; Shareholders Are Encouraged To Contact The Firm

  • By PR Newswire
  • Sep 17, 2020 4:31 PM EDT
PRESS RELEASES

Momenta Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period In Connection With Proposed Sale To Johnson & Johnson

  • By GlobeNewswire
  • Sep 15, 2020 8:00 AM EDT
No More Tears for Johnson & Johnson?
INVESTING

Johnson & Johnson Halts Development of Flu Treatment Candidate

  • By Tony Owusu
  • Sep 2, 2020 11:48 AM EDT
PRESS RELEASES

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates The Following Mergers; Shareholders Are Encouraged To Contact The Firm - MVC, PRNB, YIN, MNTA

  • By PR Newswire
  • Aug 22, 2020 5:00 AM EDT
Jim Cramer: Johnson & Johnson Will Do Well With Actelion
INVESTING

Johnson & Johnson Sets Late-Stage Vaccine Trial Next Month

  • By Rob Lenihan
  • Aug 20, 2020 3:35 PM EDT
PRESS RELEASES

Moore Kuehn Encourages NTN, PRNB, MNTA, And PFNX Investors To Contact Law Firm

  • By PR Newswire
  • Aug 20, 2020 1:44 PM EDT
PRESS RELEASES

MOMENTA INVESTOR ALERT By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of Momenta Pharmaceuticals, Inc. - MNTA

  • By Business Wire
  • Aug 20, 2020 11:42 AM EDT
PRESS RELEASES

SHAREHOLDER ALERT: WeissLaw LLP Investigates Momenta Pharmaceuticals, Inc.

  • By PR Newswire
  • Aug 19, 2020 6:35 PM EDT
PRESS RELEASES

INVESTOR ALERT: Monteverde & Associates PC Announces An Investigation Of Momenta Pharmaceuticals, Inc. - MNTA

  • By PR Newswire
  • Aug 19, 2020 2:20 PM EDT
No More Tears for Johnson & Johnson?
INVESTING

Could Momenta Deal Give Johnson & Johnson Breakout Momentum?

  • By Bret Kenwell
  • Aug 19, 2020 1:05 PM EDT
PRESS RELEASES

MOMENTA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale Of MNTA And Encourages Investors To Contact The Firm

  • By Business Wire
  • Aug 19, 2020 12:52 PM EDT
J&J, Eli Lilly Healthy for Your Portfolio Says Causeway Global Manager
Video

Johnson & Johnson Gains Drugmaker Momenta in $6.5B Deal

  • Aug 19, 2020 9:55 AM EDT
PRESS RELEASES

(MNTA) Alert: Johnson Fistel Investigates Proposed Sale Of Momenta Pharmaceuticals; Are Shareholders Getting A Fair Price?

  • By PR Newswire
  • Aug 19, 2020 7:38 AM EDT
Stocks Open Higher on Positive Earnings from J&J, Coca-Cola
MERGERS AND ACQUISITIONS

Johnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 Billion

  • By M. Corey Goldman
  • Aug 19, 2020 9:57 AM EDT
PRESS RELEASES

Momenta Pharmaceuticals Announces Date Of Second Quarter 2020 Financial Results Conference Call And Webcast

  • By GlobeNewswire
  • Aug 3, 2020 7:30 AM EDT
PRESS RELEASES

Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation For Nipocalimab In HDFN

  • By GlobeNewswire
  • Jul 28, 2020 7:15 AM EDT
PRESS RELEASES

Momenta Pharmaceuticals Announces Positive Topline Data From Interim Analysis Of Phase 2 Vivacity-MG Study Of Nipocalimab (M281) In Generalized Myasthenia Gravis (gMG)

  • By GlobeNewswire
  • Jun 15, 2020 7:05 AM EDT
PRESS RELEASES

Momenta Pharmaceuticals Announces Date Of First Quarter 2020 Financial Results Conference Call And Webcast

  • By GlobeNewswire
  • Apr 23, 2020 8:00 AM EDT
PRESS RELEASES

Momenta Provides Corporate Update Amid COVID-19 Pandemic

  • By GlobeNewswire
  • Apr 2, 2020 7:30 AM EDT
PRESS RELEASES

Momenta Pharmaceuticals To Webcast Presentation At The Cowen 40th Annual Health Care Conference

  • By GlobeNewswire
  • Feb 19, 2020 8:00 AM EST
PRESS RELEASES

Momenta Pharmaceuticals Announces Date Of Fourth Quarter And Year End 2019 Financial Results Conference Call And Webcast

  • By GlobeNewswire
  • Feb 12, 2020 8:00 AM EST
Roche CEO Bullish on U.S. Drug Market
INVESTING

Momenta Rockets After Analysts Get Bullish on Biopharma's Newest Treatment

  • By Scott Van Voorhis
  • Jan 15, 2020 11:08 AM EST
Teva Shares Fall as FDA OKs Another Generic Version of Multiple Sclerosis Drug
STOCKS

Teva shares fall as FDA OKs another generic version of multiple sclerosis drug

  • By Armie Margaret Lee
  • Feb 13, 2018 5:33 PM EST
Mylan First-Quarter Revenue Misses Estimate Amid Lower Sales of Branded Product
STOCKS

States Target Mylan President, Emcure Exec in Generic Drug Lawsuit

  • By Armie Margaret Lee
  • Nov 1, 2017 4:59 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.